BioLight Life Sciences Ltd.
(TEL Aviv Stock Exchange : BOLT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
AMRNAmarin Corporation Plc Sponsored ADR
-2.25%15.211.8%$131.96m
VRXValeant Pharmaceuticals International, Inc.
-3.46%21.3414.1%$125.57m
GWPHGW Pharmaceuticals PLC Sponsored ADR
-1.28%145.466.2%$78.47m
PRGOPerrigo Co. Plc
-2.91%46.386.8%$67.08m
SAGESAGE Therapeutics, Inc.
0.11%169.308.6%$65.12m
JAZZJazz Pharmaceuticals Plc
-1.39%129.002.3%$52.46m
HZNPHorizon Pharma plc
-1.77%27.196.7%$42.82m
PTLAPortola Pharmaceuticals, Inc.
-3.51%27.807.5%$41.62m
UTHRUnited Therapeutics Corporation
-2.58%80.7114.3%$39.76m
MDCOMedicines Company
-2.12%35.0320.3%$37.35m
ICLRICON Plc
-1.86%153.414.1%$35.69m
CTLTCatalent Inc
-3.86%53.112.4%$35.12m
ICPTIntercept Pharmaceuticals, Inc.
-3.30%60.9017.2%$33.13m
ZGNXZogenix, Inc.
-2.82%50.019.8%$22.94m
AERIAerie Pharmaceuticals, Inc.
-2.30%23.426.8%$22.84m

Company Profile

BioLight Life Sciences Ltd. engages in the research, development, and market of pharmaceutical products. It operates through the following segments: Ophthalmic and Micromedic. The Ophthalmic segment distributes topical drugs, surgical systems, and insertable platform under the following brands: Eye-D, IOPtiMate, TeaRx, LIPITEAR, and OphRx. The Micromedic segment specializes in the development and commercialization of innovative in vitro cancer diagnostic products and solutions. The company was founded on April 20, 2005 and is headquartered in Tel Aviv, Israel.